TRAITEMENT DE MALADIES APPARENTÉES AU FACTEUR DE CROISSANCE DE L'ENDOTHÉLIUM VASCULAIRE (VEGF) PAR INHIBITION DE LA TRANSCRIPTION ANTISENS NATURELLE EN VEGF
Oligonucleotide compounds modulate expression and/or function of Vascular Endothelial Growth Factor (VEGF) polynucleotides and encoded products thereof. Methods for treating diseases associated with Vascular Endothelial Growth Factor (VEGF) comprise administering one or more Oligonucleotide compounds designed to inhibit the VEGF natural antisense transcript to patients.